Search
Search Results
##search.searchResults.foundPlural##
-
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2121PDF: 831HTML: 733Table1: patient's characteristics: 237Table 2: profile of each patient: 234 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3435PDF: 1348HTML: 2377 -
-
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1550PDF: 894HTML: 3147 -
-
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1317PDF: 629HTML: 284 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
607PDF: 303HTML: 152 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4460PDF: 2040HTML: 5548Table 1: 289 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1440PDF: 646HTML: 4198 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1906PDF: 647HTML: 370 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2957PDF: 819HTML: 1328Blood Count trend before and during lenalidomide treatment: 239Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 239 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1469PDF: 646Suppl. Files: 395HTML: 183 -
-
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3352PDF: 1430HTML: 4164 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1195PDF: 1300HTML: 148 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1281PDF: 849HTML: 1795 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2609HTML: 346PDF: 971 -
DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE
2772PDF: 911HTML: 3613Diamond Blackfan Anemia: A Tertiary care centre experience: 378 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1769PDF: 880HTML: 971cover letter: 359 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3497PDF: 1045HTML: 3182flowcytometric result of peripheral blood sample: 260 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
2168HTML: 1738PDF: 1210 -
A rare case of multidrug resistant Leclercia adecarboxylata catheter-related bloodstream infection and an updated brief literature review Leclercia adecarboxylata catheter-related bloodstream infection.
1030PDF: 643HTML: 228 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5947PDF: 1611HTML: 1677Untitled: 284 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1545PDF: 633HTML: 249 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1665PDF: 839HTML: 2210Untitled: 269Untitled: 246Untitled: 242Untitled: 261Untitled: 256 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2221PDF: 845HTML: 3276







